title: Is brief psychodynamic psychotherapy in primary fibromyalgia syndrome with concurrent depression an effective treatment? A randomized controlled trial.
abstract: OBJECTIVE
  There are no studies investigating the efficacy of short-term psychodynamic psychotherapy in primary fibromyalgia syndrome (FMS). We conducted a randomized controlled trial evaluating an adapted form of individual short-term psychodynamic psychotherapy (ASTPP) versus primary care management (TAU). The study focused on FMS patients with psychiatric comorbidity.
  
  
  METHODS
  Forty-six female patients with FMS and an International Classification of Diseases, 10th Revision diagnosis of a comorbid depression or anxiety disorder were recruited in a hospital setting. Participants were randomized to receive either ASTPP (25 sessions, 1 session/week) or TAU (4 consultations/6 months). Outcome measures included the Fibromyalgia Impact Questionnaire (FIQ), the Hospital Anxiety and Depression Scale (HADS), the Pain Disability Index, the Symptom Checklist 27 and the health-related quality of life. Primary endpoints of the outcome assessment were the FIQ total score and the HADS depression scale at 12-month follow-up.
  
  
  RESULTS
  Both treatments were effective in reducing the FIQ total score (ES=0.56 and ES=0.75, respectively). Intent-to-treat analyses failed to provide evidence suggesting a marked superiority of individual psychodynamic psychotherapy as compared to TAU.
  
  
  CONCLUSIONS
  A high-standard routine treatment focusing on the improvement of health behavior and including antidepressant and analgesic medication is equally effective as a short-term individual psychodynamic psychotherapy in improving fibromyalgia-related symptoms.
authors.affiliation: Freiburg Institute of Advanced Studies, Interdisciplinary Research Groups, Albert-Ludwigs-University Freiburg, Starkenstr. 44, D 79104 Freiburg, Germany. carl.eduard.scheidt@uniklinik-freiburg.de
authors.forename: Carl Eduard
authors.initials: CE
authors.lastname: Scheidt
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Waller
authors.forename: Katharina
authors.initials: K
authors.lastname: Endorf
authors.forename: Stefan
authors.initials: S
authors.lastname: Schmidt
authors.forename: Ralf
authors.initials: R
authors.lastname: König
authors.forename: Almut
authors.initials: A
authors.lastname: Zeeck
authors.forename: Andreas
authors.initials: A
authors.lastname: Joos
authors.forename: Michael
authors.initials: M
authors.lastname: Lacour
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015897:Comorbidity; D003866:Depressive Disorder / Q000523:psychology / Q000628:therapy*; D005260:Female; D005356:Fibromyalgia / Q000503:physiopathology / Q000523:psychology*; D005858:Germany; D006801:Humans; D008875:Middle Aged; D017063:Outcome Assessment, Health Care / Q000379:methods; D011614:Psychotherapy, Brief / Q000379:methods*; D011795:Surveys and Questionnaires; D013577:Syndrome; D055815:Young Adult